Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model.
Shrestha N, Araújo F, Shahbazi MA, Mäkilä E, Gomes MJ, Airavaara M, Kauppinen EI, Raula J, Salonen J, Hirvonen J, Sarmento B, Santos HA.
Shrestha N, et al. Among authors: sarmento b.
J Control Release. 2016 Jun 28;232:113-9. doi: 10.1016/j.jconrel.2016.04.024. Epub 2016 Apr 16.
J Control Release. 2016.
PMID: 27091697